Menu
2024 Session

Budget Amendments - HB30 (Member Request)

View Budget Item
View Budget Item amendments

Chief Patron: Carr
Virginia Biosciences Health Research Corporation Authorization to Use Balances from COVID-19 Program (language only)

Item 115 #1h

Item 115 #1h

Commerce and Trade
Virginia Innovation Partnership Authority

Language

Page 117, after line 46, insert:

"9. Notwithstanding the provisions of Paragraph K.9. of Chapter 56 of the 2020 General Assembly Special Session 1, the Virginia Biosciences Health Research Corporation shall invest remaining nongeneral funds authorized in Chapter 56 for the research and development of the therapeutic drug treatments for COVID-19 in bioscience research and commercialization projects."



Explanation

This amendment authorizes the Virginia Biosciences Health Research Corporation to invest an estimated $4.3 million originally provided for investment in research and development of therapeutic drug treatments for COVID-19 in biosciences research, development, and commercialization projects.)